中华内科杂志
中華內科雜誌
중화내과잡지
CHINESE JOURNAL OF INTERNAL MEDICINE
2010年
7期
595-598
,共4页
卒中%降血脂药%门诊医疗
卒中%降血脂藥%門診醫療
졸중%강혈지약%문진의료
Stroke%Antilipemic agents%Ambulatory care
目的 研究专病门诊对他汀类药物在卒中二级预防中使用的影响.方法 回顾性总结568例在卒中门诊登记的缺血性卒中患者的人口经济学、个人既往史、LDL-C水平及他汀类药物使用等信息.结果 306例专病门诊患者的他汀类药物使用率为51.3%,而262例普通门诊患者的他汀类药物使用率仅为7.6%.在专病门诊中,71.6%有血脂异常者和44.8%无血脂异常者使用他汀类药物,明显高于普通门诊者的27.1%和2.0%.专病门诊患者中LDL-C＞3.4 mmol/L者他汀类药物使用率显著高于低于此值者(25.6%比14.7%,P=0.017).结论 普通门诊中他汀类药物使用率极低,而专病门诊则能显著提高他汀类药物的使用率,缩小了临床实践与指南的差距.
目的 研究專病門診對他汀類藥物在卒中二級預防中使用的影響.方法 迴顧性總結568例在卒中門診登記的缺血性卒中患者的人口經濟學、箇人既往史、LDL-C水平及他汀類藥物使用等信息.結果 306例專病門診患者的他汀類藥物使用率為51.3%,而262例普通門診患者的他汀類藥物使用率僅為7.6%.在專病門診中,71.6%有血脂異常者和44.8%無血脂異常者使用他汀類藥物,明顯高于普通門診者的27.1%和2.0%.專病門診患者中LDL-C＞3.4 mmol/L者他汀類藥物使用率顯著高于低于此值者(25.6%比14.7%,P=0.017).結論 普通門診中他汀類藥物使用率極低,而專病門診則能顯著提高他汀類藥物的使用率,縮小瞭臨床實踐與指南的差距.
목적 연구전병문진대타정류약물재졸중이급예방중사용적영향.방법 회고성총결568례재졸중문진등기적결혈성졸중환자적인구경제학、개인기왕사、LDL-C수평급타정류약물사용등신식.결과 306례전병문진환자적타정류약물사용솔위51.3%,이262례보통문진환자적타정류약물사용솔부위7.6%.재전병문진중,71.6%유혈지이상자화44.8%무혈지이상자사용타정류약물,명현고우보통문진자적27.1%화2.0%.전병문진환자중LDL-C＞3.4 mmol/L자타정류약물사용솔현저고우저우차치자(25.6%비14.7%,P=0.017).결론 보통문진중타정류약물사용솔겁저,이전병문진칙능현저제고타정류약물적사용솔,축소료림상실천여지남적차거.
Objective To describe the impact of stroke clinic on the usage of statins for secondary prevention of ischemic stroke.Methods Data about the demography, social economic status, personal histories, blood lipid profiles, and the status of the usage of statins from 568 serial ischemic stroke patients were retrospectively analysed.Results A total of 51.3% patients followed up in stroke clinic ( 306 patients) and 7.6% patients followed up in general clinic (262 patients) were treated with statins.71.6% patients with and 44.8% patients without hyperlipidemia in stroke clinics were taking statins, which were higher than that patients in the general clinics(27.1% and 2.0% respectively).The patients in the stroke clinics with high LDL-C level ( ＞ 3.4 mmol/L) were more likely to be treated with statins than those with lower level (25.6% vs 14.7%, P = 0.017).Conclusions The rate of statins usage is extremely low in stroke patients followed up in a general clinic, but it can been improved greatly in a stroke clinic.Stroke clinic can narrow the gap between the clinical practice and the guideline for secondary prevention of ischemic stroke.
